Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

by Marciano, Roberta, Servetto, Alberto, Bianco, Cataldo, Bianco, Roberto
Published in J Med Case Rep (2017)

c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?

by Belli, Stefania, Esposito, Daniela, Servetto, Alberto, Pesapane, Ada, Formisano, Luigi, Bianco, Roberto
Published in Cancers (Basel) (2020)

Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities

by Santaniello, Antonio, Napolitano, Fabiana, Servetto, Alberto, De Placido, Pietro, Silvestris, Nicola, Bianco, Cataldo, Formisano, Luigi, Bianco, Roberto
Published in Cancers (Basel) (2019)

Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review

by Napolitano, Fabiana, Formisano, Luigi, Giardino, Alessandro, Girelli, Roberto, Servetto, Alberto, Santaniello, Antonio, Foschini, Francesca, Marciano, Roberta, Mozzillo, Eleonora, Carratù, Anna Chiara, Cascetta, Priscilla, De Placido, Pietro, De Placido, Sabino, Bianco, Roberto
Published in Cancers (Basel) (2019)

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status

by Formisano, Luigi, D'Amato, Valentina, Servetto, Alberto, Brillante, Simona, Raimondo, Lucia, Di Mauro, Concetta, Marciano, Roberta, Orsini, Roberta Clara, Cosconati, Sandro, Randazzo, Antonio, Parsons, Sarah J., Montuori, Nunzia, Veneziani, Bianca Maria, De Placido, Sabino, Rosa, Roberta, Bianco, Roberto
Published in Oncotarget (2015)

Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers

by Di Mauro, Concetta, Rosa, Roberta, D'Amato, Valentina, Ciciola, Paola, Servetto, Alberto, Marciano, Roberta, Orsini, Roberta Clara, Formisano, Luigi, De Falco, Sandro, Cicatiello, Valeria, Di Bonito, Maurizio, Cantile, Monica, Collina, Francesca, Chambery, Angela, Veneziani, Bianca Maria, De Placido, Sabino, Bianco, Roberto
Published in Br J Cancer (2017)

FGFR1 gene amplification mediates endocrine resistance but retains TORC sensitivity in metastatic hormone receptor positive (HR+) breast cancer

by Drago, Josh, Formisano, Luigi, Juric, Dejan, Niemierko, Andrzej, Servetto, Alberto, Wander, Seth, Spring, Laura, Vidula, Neelima, Peppercorn, Jeffrey, Younger, Jerry, Malvarosa, Giuliana, Yuen, Megan, Sgroi, Dennis, Isakoff, Steven J., Moy, Beverly, Ellisen, Leif W., Iafrate, John, Arteaga, Carlos L., Bardia, Aditya
Published in Clin Cancer Res (2019)

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules

by Foschini, Francesca, Napolitano, Fabiana, Servetto, Alberto, Marciano, Roberta, Mozzillo, Eleonora, Carratù, Anna Chiara, Santaniello, Antonio, De Placido, Pietro, Cascetta, Priscilla, Butturini, Giovanni, Frigerio, Isabella, Regi, Paolo, Silvestris, Nicola, Delcuratolo, Sabina, Vasile, Enrico, Vivaldi, Caterina, Bianco, Cataldo, De Placido, Sabino, Formisano, Luigi, Bianco, Roberto
Published in Ther Adv Med Oncol (2020)

Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer

by Lee, Kyung-min, Guerrero-Zotano, Angel L., Servetto, Alberto, Sudhan, Dhivya R., Lin, Chang-Ching, Formisano, Luigi, Jansen, Valerie M., González-Ericsson, Paula, Sanders, Melinda E., Stricker, Thomas P., Raj, Ganesh, Dean, Kevin M., Fiolka, Reto, Cantley, Lewis C., Hanker, Ariella B., Arteaga, Carlos L.
Published in Nat Commun (2020)

Everolimus induces Met inactivation by disrupting the FKBP12/Met complex

by Raimondo, Lucia, D'Amato, Valentina, Servetto, Alberto, Rosa, Roberta, Marciano, Roberta, Formisano, Luigi, Mauro, Concetta Di, Orsini, Roberta Clara, Cascetta, Priscilla, Ciciola, Paola, De Maio, Ana Paula, Di Renzo, Maria Flavia, Cosconati, Sandro, Bruno, Agostino, Randazzo, Antonio, Napolitano, Filomena, Montuori, Nunzia, Veneziani, Bianca Maria, Placido, Sabino De, Bianco, Roberto
Published in Oncotarget (2016)

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors

by Mauro, Concetta Di, Pesapane, Ada, Formisano, Luigi, Rosa, Roberta, D’Amato, Valentina, Ciciola, Paola, Servetto, Alberto, Marciano, Roberta, Orsini, Roberta Clara, Monteleone, Francesca, Zambrano, Nicola, Fontanini, Gabriella, Servadio, Adele, Pignataro, Giuseppe, Grumetto, Lucia, Lavecchia, Antonio, Bruzzese, Dario, Iaccarino, Antonino, Troncone, Giancarlo, Veneziani, Bianca Maria, Montuori, Nunzia, Placido, Sabino De, Bianco, Roberto
Published in Sci Rep (2017)

Hyperactivation of TORC1 drives resistance to the pan-HER tyrosine kinase inhibitor neratinib in HER2-mutant cancers

by Sudhan, Dhivya R., Guerrero-Zotano, Angel, Won, Helen, Ericsson, Paula González, Servetto, Alberto, Rosario, Mariela H., Ye, Dan, Lee, Kyung-min, Formisano, Luigi, Guo, Yan, Liu, Qi, Kinch, Lisa N., Brewer, Monica R., Dugger, Teresa, Koch, James, Wick, Michael J., Cutler, Richard E., Lalani, Alshad S., Bryce, Richard, Auerbach, Alan, Hanker, Ariella B., Arteaga, Carlos L.
Published in Cancer Cell (2020)

Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers

by Sudhan, Dhivya R., Guerrero-Zotano, Angel, Won, Helen, Ericsson, Paula González, Servetto, Alberto, Huerta-Rosario, Mariela, Ye, Dan, Lee, Kyung-min, Formisano, Luigi, Guo, Yan, Liu, Qi, Kinch, Lisa N., Brewer, Monica Red, Dugger, Teresa, Koch, James, Wick, Michael J., Cutler, Richard E., Lalani, Alshad S., Bryce, Richard, Auerbach, Alan, Hanker, Ariella B., Arteaga, Carlos L.
Published in Cancer Cell (2020)

ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors

by Guerrero-Zotano, Angel L., Stricker, Thomas P., Formisano, Luigi, Hutchinson, Katherine E., Stover, Daniel G., Lee, Kyung-min, Schwarz, Luis J., Giltnane, Jennifer M., Estrada, Valeria M., Jansen, Valerie M., Servetto, Alberto, Gavilá, Joaquín, Perez-Fidalgo, J. Alejandro, Lluch, Ana, Llombart, Antonio, Bayar, Mohamed A., Michiels, Stefan, André, Fabrice, Arnedos, Mónica, Guillem, Vicente, Ruiz, Amparo, Arteaga, Carlos L.
Published in Clin Cancer Res (2018)

Correction: ER(+) Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

by Guerrero-Zotano, Angel L., Stricker, Thomas P., Formisano, Luigi, Hutchinson, Katherine E., Stover, Daniel G., Lee, Kyung-Min, Schwarz, Luis J., Giltnane, Jennifer M., Estrada, Monica V., Jansen, Valerie M., Servetto, Alberto, Gavilá, Joaquín, Perez-Fidalgo, J. Alejandro, Lluch, Ana, Llombart-Cussac, Antonio, Bayar, Mohamed Amine, Michiels, Stefan, André, Fabrice, Arnedos, Mόnica, Guillem, Vicente, Ruiz-Simon, Amparo, Arteaga, Carlos L.
Published in Clin Cancer Res (2019)

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

by Formisano, Luigi, Lu, Yao, Servetto, Alberto, Hanker, Ariella B., Jansen, Valerie M., Bauer, Joshua A., Sudhan, Dhivya R., Guerrero-Zotano, Angel L., Croessmann, Sarah, Guo, Yan, Ericsson, Paula Gonzalez, Lee, Kyung-min, Nixon, Mellissa J., Schwarz, Luis J., Sanders, Melinda E., Dugger, Teresa C., Cruz, Marcelo Rocha, Behdad, Amir, Cristofanilli, Massimo, Bardia, Aditya, O’Shaughnessy, Joyce, Nagy, Rebecca J., Lanman, Richard B., Solovieff, Nadia, He, Wei, Miller, Michelle, Su, Fei, Shyr, Yu, Mayer, Ingrid A., Balko, Justin M., Arteaga, Carlos L.
Published in Nat Commun (2019)